SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133616
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:30
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d234401ddef14a.htm DEF 14A 567730
2 GRAPHIC g234401g44i65.jpg GRAPHIC 30499
3 GRAPHIC g234401g63a01.jpg GRAPHIC 169371
4 GRAPHIC g234401g64a01.jpg GRAPHIC 125835
  Complete submission text file 0001193125-22-133616.txt   1014434
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39460 | Film No.: 22875303
SIC: 2836 Biological Products, (No Diagnostic Substances)